PELI1 and neoplasm: Based on these, we propose a dual mechanism through which PELI1 fosters an immunosuppressive TIME: by facilitating the development of immunosuppressive M2-type tumor-associated macrophages (TAMs) in myeloid cells and directly instigating T cell anergy in lymphocytes.